Clinical Trial Update: Dose Escalation Phase I/II Study of Lovastatin With High-Dose Cytarabine for Refractory or Relapsed AML [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II dose-escalation trial evaluating lovastatin with high-dose cytarabine for refractory or relapsed acute myeloid leukemia; study TERMINATED with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Lovastatin (Lovastatin)
• high-dose cytarabine (cytarabine)

Snippet

Sponsor: University of Iowa | Conditions: Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2018-01-05